Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Orchard Therapeutics stock jumps 13% as FDA accepts BLA for OTL-200 [Seeking Alpha]

Orchard Therapeutics plc - American Depositary Shares (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report
Company Research Source: Seeking Alpha
for its drug OTL-200 had been accepted by the FDA under its priority review program, with a decision expected by March 18. Orchard is seeking to have OTL-200 approved for the treatment of early onset metachromatic leukodystrophy, a rare and often fatal genetic disease. In addition to priority review, the product has also received Rare Pediatric Disease and Regenerative Medicine Advanced Therapy designations from the FDA. OTL-200 has already been approved by regulators in the EU and UK, where it is marketed under the brand name Libmeldy. More on Orchard Therapeutics Recommended For You Show less Read more
Impact Snapshot
Event Time:
ORTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ORTX alerts
Opt-in for
ORTX alerts

from News Quantified
Opt-in for
ORTX alerts

from News Quantified